- Pulmonary function testing (PFT) devices, offering precise measurement of lung volume, capacity, flow rates, and gas exchange, are increasingly vital components of modern respiratory diagnostics and patient monitoring systems in both clinical and home settings due to their enhanced accuracy, non-invasiveness, and comprehensive insights into lung health
- The escalating demand for PFT devices is primarily fueled by the widespread adoption of advanced diagnostic technologies, growing prevalence of respiratory diseases among consumers, and a rising preference for early detection and management of lung condition
- North America dominates the pulmonary function testing market with a market share of 38.9% characterized by a high prevalence of respiratory diseases, robust healthcare infrastructure, and a strong presence of key industry players
- Asia-Pacific is expected to be the fastest-growing region in the pulmonary function testing market during the forecast period, with a projected CAGR of 7.7%, due to increasing urbanization, rising disposable incomes, and improving healthcare infrastructure
- The obstructive lung disease application segment dominated the pulmonary function testing systems market in 2024 with a market share of 39.8%, driven by the high global prevalence of chronic obstructive pulmonary disease (COPD) and asthma and the necessity for continuous monitoring and management of these chronic conditions
